Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02408718 · ClinicalTrials.gov registry record · NA

Assistive Device Training in Multiple Sclerosis

A NA study of Multiple Sclerosis, sponsored by Portland VA Medical Center.

Completed
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT02408718 is a NA study of Multiple Sclerosis that has completed, run by Portland VA Medical Center. The registered enrollment target is 40 participants, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02408718, a NA study of Multiple Sclerosis, has completed, sponsored by Portland VA Medical Center.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine whether a training program in the use of ambulatory assistive devices (such as canes, walkers, etc) can reduce falls and increase functional mobility and neural connectivity in people with Multiple Sclerosis.

Conditions Studied

Interventions

  • BEHAVIORAL Assistive Device Training

Study Locations (1)

Oregon

  • VA Portland Health Care System - Portland

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2015-07
Est. Completion 2016-09
Phase NA

Sponsor

Portland VA Medical Center

15 total trials

What the Registry Record Tells You About NCT02408718

The ClinicalTrials.gov registry entry for NCT02408718 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (93% lower). The listed sponsor is Portland VA Medical Center, which has 15 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Multiple Sclerosis appearing as the primary indexed condition, and to 1 intervention - of which Assistive Device Training is the first listed.

NCT02408718 reports 1 study location spanning 1 distinct geographic area - top geographies include Oregon.

Frequently Asked Questions

What is clinical trial NCT02408718 about?

NCT02408718 is a clinical study titled "Assistive Device Training in Multiple Sclerosis". The purpose of this study is to determine whether a training program in the use of ambulatory assistive devices (such as canes, walkers, etc) can reduce falls and increase functional mobility and neural connectivity in people with Multiple Sclerosis.

What is the current status of trial NCT02408718?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2015-07. Estimated completion is 2016-09.

What conditions does trial NCT02408718 study?

This clinical trial studies the following conditions: Multiple Sclerosis.

What interventions are being tested in trial NCT02408718?

The interventions under investigation include: Assistive Device Training (BEHAVIORAL).

Who is sponsoring clinical trial NCT02408718?

This trial is sponsored by Portland VA Medical Center, which has 15 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02408718 being conducted?

This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Multiple Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.